Publication | Closed Access
IL‐15 and IL‐23 synergize to trigger Th17 response by CLA<sup>+</sup> T cells in psoriasis
21
Citations
19
References
2020
Year
ImmunologyImmune RegulationCd4 T Cell ResponsesDermatologyIl-17 ResponseImmunotherapyPsoriatic ArthritisImmune DysregulationInflammationExperimental DermatologyImmunopathologyIl-17a ProductionAutoimmune DiseaseTh17 ResponseClinical DermatologyAutoimmunityT Cell ImmunityCytokineIl-23 StimulationCellular Immune ResponseMedicine
IL-15 has emerged as a potentially relevant target in the IL-17 response in psoriasis. However, its mechanism is poorly characterized in humans. IL-15 and IL-23 are constitutively expressed in the psoriatic lesion. Also, IL-15 is considered a susceptibility-associated gene in psoriasis, as are IL-23R, and HLACW6. Here, we studied the effect of IL-15 and IL-23 stimulation on the cytokine response of CLA+/CLA- T cells from 9 psoriasis patients and 3 healthy control subjects. To this end, CLA + and CLA- T cells from blood samples were cultured with epidermal cells from skin biopsies and treated with IL-15 and IL-23. After five days of culture, cytokines in supernatant were measured by ELISA or fluorescent bead-based immunoassay. There was a statistically significant increase in IL-17F and IL-17A production (P < .001) in cocultures of psoriasis skin-homing CLA + T cells with epidermal cells when stimulated with IL-15 and IL-23, but this effect was not observed in the cells of healthy controls. Interestingly, this response was reduced by around 50 to 80% by blocking HLA class I and II molecules. Our results point to the synergic action of IL-15 and IL-23 selectively for CLA + cells in psoriasis, leading to the induction of Th17 cell-related cytokines.
| Year | Citations | |
|---|---|---|
Page 1
Page 1